Evidence map›Paper›PMID 31312421›Full record

Trial reportMolecular autism2019

Mechanisms underlying the EEG biomarker in Dup15q syndrome.

Joel Frohlich, Lawrence T Reiter, Vidya Saravanapandian, Charlotte DiStefano, Scott Huberty, Carly Hyde, Stormy Chamberlain, Carrie E Bearden, Peyman Golshani, Andrei Irimia and 3 more

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Molecular autism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. RO4938581, a GABAMolecular psychiatry · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Joel FrohlichRoche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.ORCID 0000-0001-8382-4344
Lawrence T Reiter4Departments of Neurology, Pediatrics and Anatomy & Neurobiology, The University of Tennessee Health Science Center, 855 Monroe Ave., Link, Memphis, TN 415 USA.
Vidya Saravanapandian2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.
Charlotte DiStefano2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.
Scott Huberty2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.
Carly Hyde2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.
Stormy Chamberlain6Genetics and Genome Sciences, UConn Health, 400 Farmington Avenue, Farmington, CT 06030-6403 USA.
Carrie E Bearden7Department of Psychiatry and Biobehavioral Sciences and Department of Psychology, University of California Los Angeles, Suite A7-460, 760 Westwood Plaza, Los Angeles, CA 90095 USA.
Peyman Golshani8Department of Neurology and Psychiatry, David Geffen School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90095 USA.
Andrei Irimia9Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Ave., Suite 228C, California, Los Angeles 90089 USA.
Richard W Olsen10Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, California, Los Angeles 90095 USA.
Joerg F Hipp *Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Shafali S Jeste *2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.
University of California, Los Angeles · USRoche (Switzerland) · CHUConn Health · USUniversity of Southern California · USUniversity of Tennessee Health Science Center · US

Funding

Understanding Repetitive Behavior in AutismP50HD055784 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BOOKHEIMER, SUSAN Y · 2007 to 2021
$32.0M
UCLA Center for Translational Research in Neurodevelopment: UC-TRaNU54HD087101 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCCRACKEN, JAMES T. · 2016 to 2020
$6.5M
Optogenetic treatment of social behavior in autismR01MH101198 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOLSHANI, PEYMAN · 2013 to 2017
$2.0M
Electrophysiological biomarkers of sleep and cognition in Dup15q syndromeR21HD099686 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JESTE, SHAFALI SPURLING · 2019 to 2020
$410k
NICHD NIH HHS P50 HD055784NICHD NIH HHS R21 HD099686NICHD NIH HHS U54 HD087101NIMH NIH HHS R01 MH101198
6 · The paper itself

Abstract

Background: Duplications of 15q11.2-q13.1 (Dup15q syndrome), including the paternally imprinted gene Methods: To test the hypothesis that Results: Peak beta power was significantly increased in the reference cohort relative to TD controls. Midazolam administration recapitulated the beta EEG phenotype in healthy adults with a similar peak frequency in central channels ( Conclusions: Our results suggest a critical role for GABAergic transmission in the Dup15q syndrome beta EEG phenotype, which cannot be explained by

Indexed as

ElectroencephalographyAdultBiomarkersChildChromosome AberrationsChromosomes, Human, Pair 15Cohort StudiesFathersFemaleHumansIntellectual DisabilityMaleMidazolamPhenotypeReceptors, GABA-ABiomarkersMidazolamReceptors, GABA-AAutismBiomarkersDup15q syndromeEEGGABAGABRA5GABRB3GABRG3Neurodevelopmental disordersUBE3A

Identifiers

PMID31312421
PMCPMC6609401
OpenAlexW2953568660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.